Skip to main content
PAS 2025 Meeting Main banner
Final Program


Schedule at a Glance
Icon Legend
Presentation Icons
Ticketed Event
Ticketed Event
Norman J. Siegel New Member Outstanding Science Award
Norman J. Siegel New Member Outstanding Science Award
John Howland Award
John Howland Award
Mary Ellen Avery Award
Mary Ellen Avery Award
SPR Thomas A. Hazinski Distinguished Service Award
SPR Thomas A. Hazinski Distinguished Service Award
SPR Douglas K. Richardson Award for Perinatal and Pediatric Healthcare Research
SPR Douglas K. Richardson Award for Perinatal and Pediatric Healthcare Research
PROSPER Diversity Award
PROSPER Diversity Award
ASPN Founders’ Award
ASPN Founders’ Award
David G. Nichols Health Equity Award
David G. Nichols Health Equity Award
ASPN Mid-Career Award
ASPN Mid-Career Award
Awarded Part 4 Maintenance of Certification (MOC) Credit
Awarded Part 4 Maintenance of Certification (MOC) Credit
Poster Icons
Awarded Part 4 Maintenance of Certification (MOC) Credit
Awarded Part 4 Maintenance of Certification (MOC) Credit
ViewAttendees 9

Allergy, Immunology and Rheumatology

Basic Science

Children with Chronic Conditions

Clinical Research

Genomics/Epigenomics

Hematology/Oncology

Infectious Diseases

Pulmonology

Trainee

New Frontiers in Gene Therapy: From the Lab to Cures for Kids

Gene Therapy for Sickle Cell Disease

Saturday, April 26, 2025
10:25am - 10:45am HST
Location:  Convention Center: 318 B

    Speaker(s)

  • Vivien A. Sheehan, MD, PhD (she/her/hers)

    Associate Professor of Pediatrics
    Emory University School of Medicine
    Atlanta, Georgia, United States

    Slides Slides
Disclosure(s):
Vivien A. Sheehan, MD, PhD: Beam Therapeutics (Ongoing) (Products/Services: Contractor including contracted research); Maxcyte (Ongoing) (Products/Services: Consultant)